Logo

PierianDx

Newly Formed Velsera Seeks Additional Acquisitions to Build Precision Medicine Platform
Premium

The new company, incorporated through a merger of the former Pierian, Seven Bridges, and UgenTec, has future ambitions in germline omics and CNS disorders.

Velsera to Integrate Arima Genomics Gene Fusion Test in Pierian Clinical Platform

Pierian, now a part of Velsera, is integrating Arima's gene fusion sequencing technology into its NGS analysis, interpretation, and reporting hub.

New Products Posted to GenomeWeb: Biodesix, Curio Genomics, Akoya Biosciences, More

PierianDx Closes Equity Financing, Loan Facility for up to $47.5M

OrbiMed was the lead investor in the new financing, which is expected to drive PierianDx's commercial expansion. The firm raised $27 million in 2019.

People in the News: New Appointments at Precipio, ERS Genomics, Omniome, PierianDx, More

Feb 4, 2021

Belgian Society of Medical Oncology to Study Value of Genomic Profiling for Cancer Patients

Dec 1, 2020

Illumina, PierianDx Expand Partnership on Cancer Panel Test Reporting

Oct 14, 2020

PierianDx, Pillar Biosciences Partner to Streamline NGS Cancer Analysis

May 5, 2020

PierianDx, University Hospital of Augsburg Tailoring NGS Workflow to European Market

Oct 28, 2019

PierianDx Raises $27M in Series B Round

Jul 1, 2019

MMRF to Bolster Recently Launched Clinical, Genomic Patient Data Registry With Immune Profiles
Premium

Mar 12, 2019

Forensic Genomics Firm Othram Raises $4M

Feb 14, 2019

Q&A: Andreessen Horowitz's Jorge Conde Discusses Power of Meshing Biology and Engineering
Premium

Jan 4, 2019

Illumina, PierianDx to Collaborate on Cancer Sequencing Assays

Jun 1, 2018

2bPrecise, PierianDx to Develop Point-of-Care Technology for Precision Medicine

May 15, 2018

PierianDx Partners With ScienceVision to Bring Clinical Genomics Platform to Asia

Apr 17, 2018

RTI, PierianDx Collaborate on Clinical Genomics Platform

Mar 14, 2018

PierianDx, Cancer Genetics Partner on Precision Cancer Medicine Offering

Feb 13, 2018

PierianDx Raises $3M in New Funding, Seeks $2M More

Mar 10, 2017

PierianDx Customers Cite 'Creative Partnership' on Clinical Genomics as Key Selling Point
Premium

Nov 2, 2015

Acquisition of Knome Assets Expands Tute Interpretation Toolkit
Premium

Nov 2, 2015

Tute Genomics Acquires Knome

Jan 12, 2015

Genalice, Knome to Jointly Offer NGS Analysis Solutions

Oct 1, 2014

Swiss Foundation Taps Genalice, Knome for Rare Disease Research

Sep 23, 2014

Knome Joins the Global Alliance for Genomics and Health

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.